Cross institutional brain data sharing agreements

Introduction

Cross-institutional brain data sharing agreements refer to formal legal arrangements between universities, hospitals, neuroscience research centres, biotechnology companies, and other scientific organisations for exchanging, accessing, storing, and analysing brain-related information. Such information may include brain imaging scans, electroencephalography (EEG) recordings, neural signals, cognitive assessment results, neurological patient records, and data generated through brain-computer interface technologies.

The development of neurotechnology has increased the importance of institutional cooperation in neuroscience research. Researchers frequently need access to large and diverse datasets to understand neurological disorders, develop neuroprosthetics, investigate cognitive functions, and improve treatments for conditions affecting the nervous system.

However, sharing brain data creates significant legal and ethical concerns because neural information may reveal highly sensitive details about an individual's identity, mental conditions, cognitive characteristics, emotional responses, and neurological functioning. Cross-institutional agreements therefore establish the legal responsibilities of participating organisations and ensure that brain data is processed according to privacy, confidentiality, research ethics, and intellectual property requirements.

Legal nature of brain data sharing agreements

A brain data sharing agreement is a legally structured document that establishes the conditions under which one institution provides neurological information to another institution. It generally identifies the permitted purposes, categories of information, access conditions, security responsibilities, ownership arrangements, and limitations on further disclosure.

These agreements may take the form of Data Sharing Agreements (DSAs), Data Use Agreements (DUAs), Research Collaboration Agreements, Material Transfer Agreements, or combined institutional contracts.

The agreement should clearly specify whether the receiving institution is permitted to use brain data only for the original research project or whether additional scientific investigations are allowed.

Important contractual provisions generally include:

Identification of participating institutions and their responsibilities.

Description of the brain data being shared.

Permitted research and analytical purposes.

Requirements for informed consent and ethical approval.

Data security and confidentiality obligations.

Restrictions on onward disclosure and commercial exploitation.

Intellectual property ownership and publication rights.

Data retention, deletion, and breach notification requirements.

Dispute resolution and institutional liability.

These provisions help prevent unauthorised reuse and establish accountability throughout the research collaboration.

Data protection and privacy requirements

Brain data can reveal sensitive information about an individual's neurological and psychological characteristics. Therefore, sharing such information requires compliance with applicable data protection legislation.

The European Union's General Data Protection Regulation (GDPR) provides an important framework. Article 4 defines personal data, while Article 9 establishes additional protections for special categories of personal data, including health data and genetic data.

Brain imaging and neural recordings may qualify as personal data when they relate to an identifiable individual. Depending on their nature and processing context, they may also constitute health data.

Article 5 establishes purpose limitation, data minimisation, accuracy, storage limitation, and confidentiality principles. Article 32 requires appropriate technical and organisational security measures.

Article 89 provides safeguards for scientific research processing, including measures designed to protect individual rights.

In India, the Digital Personal Data Protection Act, 2023 regulates the processing of digital personal data within its scope. Institutions sharing identifiable brain data must consider applicable requirements concerning lawful processing, consent, security safeguards, and the responsibilities of data fiduciaries and processors.

A significant contractual issue is determining which institution acts as the data fiduciary or controller and which institution acts as the data processor. These roles should be established according to actual decision-making responsibilities rather than merely the terminology used in the agreement.

Informed consent and research ethics

Informed consent is a fundamental requirement when brain data originates from human research participants. Individuals should receive appropriate information about the nature of the research, the categories of neurological information collected, the participating institutions, and the intended use of their information.

Consent documentation should address whether brain data may be shared with external research organisations, transferred internationally, retained for future studies, or used for commercial research.

Where the proposed secondary use goes beyond the original consent, institutions must assess whether additional consent, ethics committee approval, or another lawful basis is necessary.

In India, the Indian Council of Medical Research (ICMR) National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017 provide important guidance on informed consent, confidentiality, privacy, and ethical research governance.

Institutional Ethics Committees should evaluate the scientific purpose, participant protection measures, and potential risks associated with sharing neurological datasets.

Special attention is necessary when research involves children, individuals with impaired decision-making capacity, or patients receiving experimental neurotechnology interventions.

Intellectual property and ownership rights

Cross-institutional brain data sharing also raises questions concerning ownership and control of research outputs. A participating hospital may generate brain imaging data, while a university may develop analytical algorithms and another research institution may identify new neurological patterns.

The agreement should distinguish between raw research data, processed datasets, analytical methods, software, algorithms, and inventions developed through collaborative research.

The contractual arrangement should clarify:

Ownership of pre-existing research materials and intellectual property.

Rights over newly generated research outputs.

Permitted commercial and non-commercial uses.

Publication and authorship responsibilities.

Patent filing and licensing arrangements.

Restrictions on transferring confidential research materials to third parties.

The TRIPS Agreement, particularly its provisions concerning intellectual property protection and undisclosed information, provides an international framework relevant to protecting confidential scientific knowledge.

However, access to brain data does not automatically grant the receiving institution ownership of the underlying personal information or associated intellectual property.

Cybersecurity and confidentiality obligations

Brain data sharing requires strong cybersecurity arrangements because unauthorised access may expose sensitive neurological and medical information.

Participating institutions should implement appropriate technical and organisational safeguards, including encryption, access authentication, secure research environments, audit logs, and controlled data transmission.

Agreements should also establish procedures for reporting security incidents, investigating breaches, notifying affected institutions, and complying with applicable legal reporting requirements.

Particular care is necessary when cloud computing platforms or international research databases are used. Institutions must determine where the data is stored, which entities can access it, and whether international transfer restrictions apply.

Confidentiality obligations should continue even after the research collaboration or institutional agreement has ended.

International transfer of brain data

International neuroscience research often involves institutions operating in different legal jurisdictions. Consequently, brain data sharing agreements must address differences in national privacy laws, research ethics requirements, and international transfer restrictions.

Under GDPR Articles 44–49, transfers of personal data outside the European Economic Area must satisfy applicable international transfer requirements. Depending on the circumstances, institutions may rely on adequacy decisions, Standard Contractual Clauses, or other recognised mechanisms.

In India, Section 16 of the Digital Personal Data Protection Act, 2023 empowers the Central Government to restrict transfers of personal data to notified countries or territories.

International agreements should therefore specify the applicable jurisdiction, transfer mechanism, security requirements, and responsibilities of participating institutions.

Important judicial decisions and case laws

1. Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1

The Supreme Court of India recognised privacy as a fundamental right under Article 21 of the Constitution. The judgment emphasised individual autonomy, dignity, and informational privacy.

Its principles are particularly relevant to cross-institutional brain data sharing because neural information may reveal deeply personal details concerning an individual's neurological and mental functioning.

The judgment supports the need for lawful processing, appropriate safeguards, and protection against arbitrary disclosure of sensitive personal information.

2. Commonwealth v. Christopher T. (2014) — Not a verified brain-data precedent

This reference should not be relied upon as an established judicial authority concerning neurotechnology. More relevant and verifiable authorities are discussed below.

2. S and Marper v. United Kingdom, Applications Nos. 30562/04 and 30566/04 (ECtHR, 2008)

The European Court of Human Rights examined the retention of fingerprints and DNA profiles of individuals who had not been convicted of offences.

The Court held that indiscriminate retention of such personal information violated Article 8 of the European Convention on Human Rights.

The judgment is relevant to brain data governance because it demonstrates that sensitive biological information requires proportionate collection, retention, and use. Research institutions should therefore avoid retaining or sharing identifiable neurological information without an appropriate legal justification.

3. Digital Rights Ireland Ltd v. Minister for Communications, Joined Cases C-293/12 and C-594/12 (CJEU, 2014)

The Court of Justice of the European Union invalidated the Data Retention Directive because its broad data-retention framework disproportionately interfered with fundamental privacy and data protection rights.

The judgment is relevant to institutional brain data sharing because it highlights the importance of necessity and proportionality when collecting, storing, and exchanging large quantities of sensitive information.

4. Schrems II (Data Protection Commissioner v. Facebook Ireland Ltd.), Case C-311/18 (CJEU, 2020)

The Court examined the legal requirements governing international transfers of personal data from the European Union to the United States.

It invalidated the EU–US Privacy Shield and emphasised the need for effective safeguards when personal information is transferred to another jurisdiction.

The decision is important for international neuroscience collaborations involving brain imaging, neural recordings, and patient information. It demonstrates that contractual agreements must be supported by appropriate legal and practical safeguards.

5. Montgomery v. Lanarkshire Health Board, [2015] UKSC 11

The United Kingdom Supreme Court established important principles concerning informed consent in medical treatment. It held that medical professionals must take reasonable care to ensure patients are aware of material risks and reasonable alternative treatment options.

Although the judgment concerned medical treatment rather than research data sharing, its informed-consent principles are relevant to neuroscience research involving human participants. Research institutions should provide meaningful information about the collection, sharing, and intended use of brain data.

Responsibilities of participating institutions

Universities, hospitals, neuroscience laboratories, and technology companies must establish clear institutional governance mechanisms before exchanging neurological datasets.

Their responsibilities include:

Obtaining appropriate participant consent or identifying another valid legal basis.

Securing Institutional Ethics Committee approval where required.

Establishing legally enforceable data-sharing agreements.

Verifying the identity and authority of receiving institutions.

Restricting access to authorised researchers.

Protecting identifiable neurological and medical information.

Preventing unauthorised commercial reuse.

Maintaining data access and transfer records.

Establishing breach reporting and response procedures.

Ensuring compliance with applicable international transfer regulations.

Institutions should also conduct periodic compliance reviews to determine whether research activities remain consistent with the original agreement and approved research objectives.

Challenges in cross-institutional brain data governance

One of the principal challenges is the absence of a universally harmonised legal framework specifically governing neural data sharing. Different jurisdictions classify and protect neurological information differently.

Another challenge concerns technological developments. Advanced brain-computer interfaces and artificial intelligence systems can extract additional information from neural recordings. Consequently, information initially collected for one scientific purpose may reveal new personal characteristics when analysed using advanced computational methods.

Other significant challenges include:

Unclear ownership of jointly generated research datasets.

Differences in institutional ethical approval standards.

International restrictions on transferring sensitive information.

Risks of re-identification through combined datasets.

Commercial exploitation of neurological research information.

Unauthorised access by external technology providers.

Difficulty enforcing contractual restrictions across jurisdictions.

These challenges require institutions to adopt flexible agreements that can accommodate technological developments while preserving individual rights and research integrity.

Conclusion

Cross-institutional brain data sharing agreements are essential legal instruments for facilitating responsible neuroscience research and international scientific collaboration. They establish the rights, responsibilities, and obligations of universities, hospitals, research laboratories, and technology companies exchanging neurological information. Legal frameworks such as the GDPR, India's Digital Personal Data Protection Act, 2023, and international intellectual property standards provide important regulatory foundations. Judicial decisions including Puttaswamy, S and Marper, Digital Rights Ireland, Schrems II, and Montgomery offer relevant principles concerning privacy, proportionality, international data transfers, and informed consent. Ultimately, effective agreements must balance scientific progress with neural privacy, confidentiality, cybersecurity, research ethics, and institutional accountability.